Clinical Trial Update: Long-term Follow-up Gene Therapy Study for RPGR- XLRP

View source ↗

Summary

This entry reports a completed long-term follow-up of a gene therapy trial for RPGR-XLRP (X-Linked Retinitis Pigmentosa) sponsored by Janssen Research & Develop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinitis Pigmentosa

Drugs mentioned

• RPGR-XLRP gene therapy (AAV-RPGR) (RPGR gene therapy)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: X-Linked Retinitis Pigmentosa | Status: COMPLETED